Lin, W., Chou, J., Yen, H., Hsu, W., Lin, H., Lin, J., . . . Wong, J. (2017). Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study. Intest Res.
Citación estilo ChicagoLin, Wei-Chen, et al. "Outcomes of Limited Period of Adalimumab Treatment in Moderate to Severe Crohn's Disease Patients: Taiwan Society of Inflammatory Bowel Disease Study." Intest Res 2017.
Cita MLALin, Wei-Chen, et al. "Outcomes of Limited Period of Adalimumab Treatment in Moderate to Severe Crohn's Disease Patients: Taiwan Society of Inflammatory Bowel Disease Study." Intest Res 2017.
Precaución: Estas citas no son 100% exactas.